Data-Gouv-ML/pcri-informations-sur-les-projets-laureats huggingface dataset:
Enhancing the innovation management capacities of SMEs in West Poland (KAM2WestPoland)

Framework: Horizon 2020 — Industrial Leadership
Programme: Innovation in SMEs
Action type: Specific Grant agreement
Countries involved: Poland,Poland,Poland,Poland,Poland,Poland,Poland,Poland
Call: Enhancing the innovation management capacity of SMEs (H2020-Adhoc-2014-20, 2014)
Start date: 2015-01-01
End date: 2016-12-31
Duration (months): 24.0
Total project cost (EUR): 66500.0
EU funding (EUR): 66500.0
Participants: 9
Project status: CLOSED

The objective of the project is to contribute to and enhance the innovation potential and innovation management skills within the SMEs in the West Poland area. The project will follow a developed methodology to help the regional businesses to increase their innovation capacity and to innovate profitably. The project will be implemented via 2 specific schemes: 1) Service ‘Key account management for SME Instrument beneficiaries’. This service will be aimed at SMEs which will be successful in applying for the SME Instrument Programme under the Horizon 2020 (Phase I or Phase II). Upon the receipt of the information (potential beneficiary’s contact details) from the EC/EASME, the project partner will contact the potential beneficiary in order to explain the service and convince the SME to use the potential it offers. 2) Service: ‘Enhancing the innovation management capacity of SME’s’. This service will be aimed at promising SMEs capable of growth and successful internationalisation that have real potential for innovation via proper development of their products, processes, services or business model but who lack the right skills, knowledge and experience to manage the innovation activities. The aim of this scheme is to first of all support those SMEs in order to make them unlock their potential for better management of the processes linked to innovation. The project will be implemented as a testing phase from January 2015 until December 2016.

Keywords: innovation management,capacity building,innovation expert,sme instrument,key account,management,horizon 2020,enhancing innovation performance
SURveillance Video Archives iNvestigation assisTant (SURVANT)

Framework: Horizon 2020 — Societal Challenges
Action type: Innovation actions
Countries involved: Ireland,Italy,Spain,Italy,Greece
Call: Fast Track to Innovation Pilot (H2020-FTIPilot-2015-1, 2015)
Start date: 2017-01-01
End date: 2018-12-31
Duration (months): 24.0
Total project cost (EUR): 2578960.0
EU funding (EUR): 1994797.0
Participants: 6
Project status: CLOSED

All around the world, organizations and agencies deploy video surveillance to monitor and protect property and public infrastructure, driven by various factors like increasing crime rate, security threats, terrorism acts and even monitoring of law enforcement. The influx of surveillance footage from a growing number of cameras operating at higher resolutions, such as HD, coupled with the desire to increase the retention time of that footage is exploding the volume of the footage available. Organizations that have invested heavily in surveillance infrastructure are keen to exploit it for the automation of surveillance procedures using video analytics solutions. SURVANT will deliver an innovative system that will collect the relevant videos from heterogeneous repositories, extract video analytics, enrich the analytics using reasoning and inference technologies, and offer a unified search interface to the user. An intuitive interface with a relaxed learning curve will assist the user create accurate search queries and receive the results using advanced visualization tools. Ethical management of personal data collected from surveillance videos is integrated in the system design. SURVANT is the follow up of the research project ADVISE (GA 285024), co-financed by EU in the FP7 Work programme in the SEC-2011 call. It intends to market uptake the results achieved in ADVISE and prove the final system at operational environment (TRL9). The market opportunity has been confirmed during the ADVISE project demonstration workshops, where end-users were enthusiastic about the functionality of the prototype presented and some initial interest for purchasing the system was declared. Law Enforcement Agencies (LEAs), critical infrastructure operators and private security organizations are the primary market targets of this action. However, SURVANT pleads to explore new markets that share common needs.

Keywords: secure societies,video surveillance,cctv,heterogeneous video archives,automated video analysis,visual analytics,security event discovery,event prediction,privacy by design,anonymisation
Bio-orthogonal catalysis for cancer therapy (THERACAT)

Framework: Horizon 2020 — Excellent Science
Programme: Marie-Sklodowska-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Innovative Training Networks (ITN)-European Training Networks
Action type: Marie Skłodowska-Curie actions
Panel: Chemistry
Countries involved: Israel,Spain,Switzerland,Netherlands,Netherlands,Netherlands,United Kingdom,United Kingdom
Call: Innovative Training Networks (H2020-MSCA-ITN-2017, 2017)
Start date: 2018-03-01
End date: 2022-08-31
Duration (months): 54.0
Total project cost (EUR): 3380767.25
EU funding (EUR): 3380767.25
Participants: 9
Project status: CLOSED

THERACAT is an international and multidisciplinary consortium aiming at the training of 13 ESRs on the innovative topic of novel bio-orthogonal catalysis-based tools for cancer therapy. This ETN comprises 6 academic partners, 3 industrial partners active in the pharmaceutical market (1 large pharmaceutical company, Teva, and 2 SMEs, BiogelX and Tagworks) and 3 partners with focus on science communication (Cancer research UK), gender and minorities (UAB-Observatory for Equality) and management and entrepreneurship (ESADE business school). The combination of academic, private and society-involved organisations will provide a broad training for the 13 ESRs recruited, equipping them with the necessary skills to succeed as scientists, industrial researchers and entrepreneurs. The development of novel cancer therapies is a major challenge for academic research and pharmaceutical industries. THERACAT aims to establish a training programme focused on the development of THERApeutic CATalysts. In this strategy, materials bearing a catalytic unit are delivered to the tumour and subsequently non-active prodrugs are administered. The prodrugs are non-toxic and therefore generate limited side effects. Only at the tumour site the catalytic particles convert the prodrugs into active compounds that generate a therapeutic effect. This approach presents several advantages on the classical drug delivery paradigm including limited side effects and prolonged efficacy. This multidisciplinary research programme will be the setting for the training of 13 ESRs. The combination of the research expertise, the cutting-edge facilities and the complementary skills present in the consortium holds a great promise for the advancement of their careers, as well as of the knowledge of catalysis-based anticancer therapies and the development of marketable technologies and products.

Keywords: bio orthogonal catalysis,nanomedicine,catalysis in living cells,chemical biology
Novel Device for Improving Ostomy Skin Condition (OSTOFORM)

Framework: Horizon 2020 — Industrial Leadership
Programme: Innovation in SMEs
Action type: SME instrument
Countries involved: Ireland
Call: SME instrument (H2020-SMEInst-2018-2020-2, 2019)
Start date: 2019-04-01
End date: 2021-10-31
Duration (months): 31.0
Total project cost (EUR): 1835801.25
EU funding (EUR): 1285060.88
Participants: 1
Project status: CLOSED

Ostoform is a spin-out medical device company from the University of Limerick, Ireland with a range of patented technologies, and the potential to scale, becoming a global leader in the area of ostomy skin health. There is enormous opportunity to address needs in the ostomy market, with 40% of all ileostomy and urostomy patients suffering from skin complications. The Ostoform Seal- the company’s first, award-winning product- uses a unique, patented combination of absorbent and non-absorbent materials to prevent acidic output from contacting the patient’s skin. Patient benefits of this product include healthier skin, better usability, increased patient confidence and improved patient quality of life. The devicecan also reduce costs for healthcare systems by reducing visits to ostomy nurses and by reducing the frequency with whichpatients change their ostomy bags. The addressable patient population for the Ostoform Seal is approximately 1,000,000 in the EU and US combined, resulting in an annual market of $725m. The device is a Class I medical device with a clear regulatory pathway and pre-existing reimbursement in the US. A 45% improvement in skin condition has already been demonstrated in a six-week study involving 12 patients. Following completion of the SME Instrument Phase I, Ostoform has secured €1.1m in private investment. This capital, along with SME Instrument Phase 2 funding will support further patient trials, which in turn will improve reimbursement pricing for the device. A full manufacturing line will also be established, with the company being fully market ready by December 2020.

Keywords: ostomy
Innovative cable car for urban transport (CABLESMART)

Framework: Horizon 2020 — Industrial Leadership
Programme: Innovation in SMEs
Action type: SME instrument
Countries involved: Italy
Call: SME instrument (H2020-SMEInst-2018-2020-1, 2018)
Start date: 2018-05-01
End date: 2018-08-31
Duration (months): 4.0
Total project cost (EUR): 71429.0
EU funding (EUR): 50000.0
Participants: 1
Project status: CLOSED

Urban population is rising, demanding a greener and more efficient urban public transport. Indeed, traditional public transport modes – railways, subways, tramways, busses – have significant construction & exploitation costs, and high pollution & energy consumption. Despite a lower impact on urban fabric, current cableways are hindered by reduced reliability, limited safety, and high operation & maintenance cost that make unfeasible to install and operate a complete urban network. To overcome those limitations, Dimensione ingenierie Srl (D.I.), Italian company with more than 30-years-experience team in cableway engineering & construction, is developing CableSmart, the first cableway alternative to provide a complete urban transport network: sustainable & green urban transport solution, CableSmart allows mobility and better accessibility to steeper areas, facilitating logistics, serving business and citizens. Our technology is based on smart, self-propelled and energy efficient cabins (-70% reduced energy consumption, 50% of which produced by integrated solar panels). With a capacity for 5,000 passenger/hour (10 people/cabin) and a cableway network that can reach >10km, CableSmart is the new solution for urban transport. CableSmart offers a competitive solution with low construction (≤€10M/km) and exploitation costs (€0.3 /passenger), for a payback period ≤ 6 years. CableSmart successful launch will be by 2021: after 5 years of exploitation, we expect to sell 11 CableSmart units, boosting our revenues and gross profits to respectively €135M and €33M by the 5th year of exploitations, and creating 65 new job opportunities.

Keywords: cable car,cableway,ropeway,urban transport,public transport,urban mobility,green transport,self propelled,solar panel,storage batteries,electric motors
ThErmAl Probes Of fractional quantum hall Transport (TEAPOT)

Framework: Horizon 2020 — Excellent Science
Programme: Marie-Sklodowska-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Individual Fellowships (IF)-Standard European Fellowships
Action type: Marie Skłodowska-Curie actions
Panel: Physics
Countries involved: Sweden
Call: Individual Fellowships (H2020-MSCA-IF-2020, 2020)
Start date: 2022-01-01
End date: 2024-01-19
Duration (months): 24.0
Total project cost (EUR): 203852.16
EU funding (EUR): 203852.16
Participants: 1
Project status: SIGNED

In a strong magnetic field and at extremely low temperatures, a two-dimensional sheet of electrons can transition into a strongly correlated state: the fractional quantum Hall (FQH) state. The one-dimensional edge of such a sheet is by itself a viable experimental platform for controlled studies of a wide range of quantum phenomena. Recent experimental developments have enabled detailed thermal transport experiments for probing the properties of such FQH edges. Despite this progress, many questions on edge energy propagation, equilibration, and redistribution remain unanswered. The theoretical TEAPOT project will address these questions by introducing new observables - heat noise, mixed noise and delta-T noise -for disordered transport on general FQH edges. The main goal is to use these promising quantities as novel and complementary tools for probing emergent transport phenomena, not directly or not uniquely related to the electrical charge. TEAPOT will be led by the experienced researcher (ER), as a postdoc project in collaboration with the Supervisor: an expert on quantum thermodynamical processes in nanoscale devices. The ER has recently developed a theoretical model connecting the propagation of charge, heat, and charge noise on general FQH edges. With this substantial preparation, TEAPOT will reach its goal by generating a full theoretical description of the interrelated edge propagation of charge, heat, charge noise, heat noise, delta-T noise, and mixed noise. This description will be derived by the ER and the Supervisor, combining chiral Luttinger liquid techniques with concepts in quantum thermodynamics. TEAPOT will enable novel ways to design and analyze FQH experiments, improving the fundamental understanding of strongly correlated quantum behaviour on the nanoscale. In turn, such an understanding is crucial for the design of novel types of quantum devices, e.g., for small scale thermodynamical or quantum computational applications.

Keywords: fractional quantum hall effect,chiral edge states,chiral luttinger liquid,noise,quantum transport
Navigating the Roadmap for Clean, Secure and Efficient Energy Innovation (SET-Nav)

Framework: Horizon 2020 — Societal Challenges
Programme: Secure, clean and efficient energy
Theme: Robust decision making and public engagement
Action type: Research and Innovation actions
Countries involved: Spain,Austria,Germany,Germany,Germany,Austria,Switzerland,Norway,Greece,Switzerland,Belgium,Hungary,France,United Kingdom
Call: Modelling and analysing the energy system, its transformation and impacts (H2020-LCE-2015-2, 2015)
Start date: 2016-04-01
End date: 2019-03-31
Duration (months): 36.0
Total project cost (EUR): 3999411.25
EU funding (EUR): 3999411.25
Participants: 17
Project status: CLOSED

SET-Nav will support strategic decision making in Europe’s energy sector, enhancing innovation towards a clean, secure and efficient energy system. Our research will enable the EC, national governments and regulators to facilitate the development of optimal technology portfolios by market actors. We will comprehensively address critical uncertainties and derive appropriate policy and market responses. Our findings will support the further development of the SET-Plan and its implementation by continuous stakeholder involvement. These contributions of the SET-Nav project rest on three pillars: The wide range of objectives and analytical challenges set out by the call for proposals can only be met by developing a broad and technically-advanced modelling portfolio. Advancing this portfolio and enabling knowledge exchange via a modelling forum is our first pillar. The EU’s energy, innovation and climate challenges define the direction of a future EU energy system, but the specific technology pathways are policy sensitive and need careful comparative evaluation. This is our second pillar. Using our strengthened modelling capabilities in an integrated modelling hierarchy, we will analyse multiple dimensions of impact of future pathways: sustainability, reliability and supply security, global competitiveness and efficiency. This analysis will combine bottom-up ‘case studies’ linked to the full range of SET-Plan themes with holistic ‘transformation pathways’. Stakeholder dialogue and dissemination is the third pillar of SET-Nav. We have prepared for a lively stakeholder dialogue through a series of events on critical SET-Plan themes. The active involvement of stakeholders in a two-way feedback process will provide a reality check on our modelling assumptions and approaches, and ensure high policy relevance. Our aim is to ensure policy and market actors alike can navigate effectively through the diverse options available on energy innovation and system transformation.

Keywords: energy innovation,modelling,strategic policy analysis,comparative assessment,set plan,stakeholder dialogue
A longitudinal assessment of treatment experience, symptoms and potential associations with biomarkers in cancer patients undergoing immune checkpoint inhibitor therapy (PaSION)

Framework: Horizon 2020 — Excellent Science
Programme: Marie-Sklodowska-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Individual Fellowships (IF)-Society and Enterprise panel
Action type: Marie Skłodowska-Curie actions
Panel: Life Sciences
Countries involved: Switzerland
Call: Individual Fellowships (H2020-MSCA-IF-2017, 2017)
Start date: 2018-09-01
End date: 2020-08-31
Duration (months): 24.0
Total project cost (EUR): 175419.6
EU funding (EUR): 175419.6
Participants: 1
Project status: CLOSED

Immuno-oncology (IO) and specifically immune checkpoint inhibitors (ICIs) have recently shown significant clinical benefit in a growing number of different tumor types. However 60-90% of the patients experience immune-related adverse events (irAEs) associated with inflammatory or autoimmune responses that can affect any organ and system. Early recognition and treatment of these irAEs is crucial to reduce morbidity, organ complications and ultimately, mortality. Patient reported outcomes (PROs) result in earlier detection of symptom occurrence and severity compared to clinician reports, which tend to understate these experiences, and can serve as a reliable complementary indicator for AEs before their clinical manifestation. Although the use of PROs is highly recommended to be included as an endpoint in clinical trials, no IO-specific-PRO tool has been developed to date and the use of general cancer-specific instruments does not address the needs, concerns and specific symptoms experienced by patients undergoing ICI therapy. The overall objective of this project is therefore to gain a comprehensive understanding of patients’ experience over the immunotherapeutic treatment course based on qualitative interviews with patients, their caregivers and healthcare professionals. This will enable evaluating the need for adaptation or development of new IO-PRO measures. Furthermore, variations in immune-related biomarkers might predict the appearance and severity of symptoms and serve as surrogates for high-grade AEs risk stratification. Hence, this project will additionally investigate potential associations between symptoms and biomarkers over the treatment course in order to elucidate existing correlations. Results derived from this study will facilitate the development of more efficient and targeted care interventions based on the characteristics of the individual in the future, together advancing a patient-centered model of care in IO.

Keywords: nursing,care,patient reported outcome,symptom,quality of life,patient experience,biomarker,cancer immunotherapy,immune checkpoint inhibitor
Quick Disconnect System (QUICK)

Framework: Horizon 2020 — Societal Challenges
Programme: Smart, green and integrated transport
Theme: Public-private partnerships
Destination: Clean Sky 2
Action type: Innovation actions
Partnership: CS2 (Art-187)
Countries involved: United Kingdom
Call: Quick Disconnect System (H2020-CS2-CFP07-2017-02, 2017)
Start date: 2018-11-01
End date: 2022-10-31
Duration (months): 48.0
Total project cost (EUR): 599386.25
EU funding (EUR): 599386.25
Participants: 1
Project status: CLOSED

The Quick Disconnect System (QUICK) project brings the world leading expertise in mechanical, electrical and control engineering focused on aerospace applications at the University of Nottingham (UNOTT) to design, develop, manufacture, test and qualify up to demonstrator test levels, a quick disconnect system intended to be installed on future energy-optimised aircraft. A novel, highly robust and reliable fault detection and mechanical isolation system will be developed aimed at reducing the risks associated with potentially highly dissipative failure modes that high-performance electrical power generator technologies will require in the near future. Delivery of the QUICK system will be supported by UNOTT’s innovative design and prototyping capabilities and underpinned by UNOTT’s internal quality control (QC) and commercial experience. UNOTT has a proven record of working across the range of technology readiness levels (TRL), from fundamental research up to flight demonstrators for aircraft technologies, up to TRL 6. This includes the required simulations and physical hardware testing. UNOTT has world leading laboratory-based test facilities for electrical and mechanical systems including, electrical machines (EM), power electronics (PE) and aircraft electrical systems (see Section BII). Such examples include • Electric taxiing motor, realised up to TRL5 • FIRS3T power electronics for stop/start systems, realised up to TRL7 • AEGART starter-generator and associated PE, realised up to TRL5 • HEMAS actuator systems, realised up to TRL5 • Helicopter landing gear equipment for extraction/retraction and steering • Various power generations products

Keywords: electrical machine,electrical generator,hybrid propulsion